MG PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MG PHARMA
Largest movements
- Receivables within one year +€57,279
up €57,279 (+23.1%), from €248,176 to €305,455
of which Other amounts receivable: +€36,306
- Financial fixed assets +€13,876
up €13,876 (+2.2%), from €626,749 to €640,624
- Debts after one year -€139,599
down €139,599 (-32.0%), from €436,175 to €296,576
of which Other amounts payable: -€92,356
- Tax, wage and social debts +€81,536
up €81,536 (+229.9%), from €35,465 to €117,001
- Short-term financial debts +€73,383
new in 2022: €73,383
- Trade debts +€51,707
up €51,707 (+13.1%), from €394,290 to €445,997
- Gross operating margin -€38,102
down €38,102 (-66.1%), from €57,626 to €19,525
- Taxes -€13,876
no longer reported in 2022 (was €13,876)
- Financial charges -€675
down €675 (-5.0%), from €13,394 to €12,720
From the 2021 result to the 2022 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2021 and 2022 balance sheets and the 2022 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2021 | 2022 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,037,537 | €1,100,769 | +€63,232 | +6.1% |
| Fixed assets | 21/28 | €785,749 | €789,024 | +€3,276 | +0.4% |
| Tangible fixed assets | 22/27 | €159,000 | €148,400 | -€10,600 | -6.7% |
| Land and buildings | 22 | €159,000 | €148,400 | -€10,600 | -6.7% |
| Financial fixed assets | 28 | €626,749 | €640,624 | +€13,876 | +2.2% |
| Current assets | 29/58 | €251,789 | €311,745 | +€59,957 | +23.8% |
| Amounts receivable within one year | 40/41 | €248,176 | €305,455 | +€57,279 | +23.1% |
| Trade receivables | 40 | €248,176 | €269,148 | +€20,972 | +8.5% |
| Other amounts receivable | 41 | - | €36,306 | +€36,306 | |
| Cash at bank and in hand | 54/58 | €3,612 | €6,290 | +€2,678 | +74.1% |
| Total equity and liabilities | 10/49 | €1,037,537 | €1,100,769 | +€63,232 | +6.1% |
| Equity | 10/15 | €171,607 | €167,812 | -€3,795 | -2.2% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Capital | 10 | €18,592 | €18,592 | = | 0.0% |
| Issued capital | 100 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €1,859 | €1,859 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Legal reserve | 130 | €1,859 | €1,859 | = | 0.0% |
| Profit (loss) carried forward | 14 | €151,156 | €147,361 | -€3,795 | -2.5% |
| Amounts payable | 17/49 | €865,930 | €932,957 | +€67,027 | +7.7% |
| Amounts payable after more than one year | 17 | €436,175 | €296,576 | -€139,599 | -32.0% |
| Financial debts | 170/4 | €343,818 | €296,576 | -€47,242 | -13.7% |
| Other amounts payable | 178/9 | €92,356 | - | -€92,356 | |
| Amounts payable within one year | 42/48 | €429,755 | €636,381 | +€206,626 | +48.1% |
| Financial debts | 43 | - | €73,383 | +€73,383 | |
| Credit institutions | 430/8 | - | €73,383 | +€73,383 | |
| Trade debts | 44 | €394,290 | €445,997 | +€51,707 | +13.1% |
| Suppliers | 440/4 | €394,290 | €445,997 | +€51,707 | +13.1% |
| Taxes, remuneration and social security | 45 | €35,465 | €117,001 | +€81,536 | +229.9% |
| Taxes | 450/3 | €35,465 | €117,001 | +€81,536 | +229.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,600 | €10,600 | = | 0.0% |
| Gross operating margin | 9900 | €57,626 | €19,525 | -€38,102 | -66.1% |
| Operating profit (loss) | 9901 | €47,026 | €8,925 | -€38,102 | -81.0% |
| Financial charges | 65/66B | €13,394 | €12,720 | -€675 | -5.0% |
| Recurring financial charges | 65 | €13,394 | €12,720 | -€675 | -5.0% |
| Profit (loss) for the period before taxes | 9903 | €33,632 | -€3,795 | -€37,427 | |
| Income taxes | 67/77 | €13,876 | - | -€13,876 | |
| Profit (loss) for the period | 9904 | €19,757 | -€3,795 | -€23,552 | |
| Profit (loss) for the period to be appropriated | 9905 | €19,757 | -€3,795 | -€23,552 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2021 and 31 December 2022. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.